A settlement has been reached, with a major retailer agreeing to pay a significant amount. The company will provide $50 million to resolve allegations. Claims were made that certain prescriptions were filled improperly, involving opioids and other substances.

The allegations date back to 2013 and were raised by government attorneys in 2020. Further details about the claims and the settlement are available.

The payment is intended to address the company's alleged role in a national health issue. More information can be found through the original report.